Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA Establishes Coordinating Organization to Prepare for PIC/S Membership
August 1, 2011
- Eisai's Halaven “Extremely Convenient for Outpatients”: Dr Iwata of Aichi Cancer Center
August 1, 2011
- Equa Ranked No. 1 Both in HP, GP Markets for 2nd Straight Month: RepTrack Survey
August 1, 2011
- Generic Drugmakers Still Reluctant to File for Add'l Indications Based on Info in Public Domain
August 1, 2011
- JPA Urges Member Pharmacies to Participate in JCQHC-initiated Accident Reporting Project
August 1, 2011
- Japanese Pharm. Industry Needs Aggressive Globalization: Dr Kato of EFPIA Japan
August 1, 2011
- Premium for New Drug Development Should Be Made Permanent: Mr Wolf of PhRMA
August 1, 2011
- Asahi Kasei to Enter Market for Medical Devices for Emergency Care Aiming at ¥100 Bil. Sales
August 1, 2011
- Shionogi to Acquire 9 Products from Victory Pharma of the US
August 1, 2011
- FDA's Advisory Committee Does Not Recommend Approval of Dapagliflozin
August 1, 2011
- Korosho, PMDA Providing Risk Info on Drugs Under Review on Websites
August 1, 2011
- LTT Bio-Pharma to License Inhalant PC-SOD to CKD in South Korea
August 1, 2011
- Transfer of Part of PMDA Functions to Osaka Proposed in Kansai Sogo Tokku Plan
August 1, 2011
- Astellas Licenses Transplant Viremia Prevention Vaccine from Vical
August 1, 2011
- Chugai Applies for Approval of Pulmozyme for Cystic Fibrosis
August 1, 2011
- Mochida, MTPC to Launch Lexapro on Aug. 22
August 1, 2011
- Sodium Phenylbutyrate from CMIC Designated as Orphan Drug
August 1, 2011
- Nihon Chouzai to Introduce Finger Vein Authentication at All Stores
August 1, 2011
- NPhA Withdraws Request to Refrain from Offering Points for Dispensing Services
August 1, 2011
- Ain Pharmaciez to Improve Its Services for Patients Using Smart Phones
August 1, 2011
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…